2021
DOI: 10.1021/acs.molpharmaceut.1c00122
|View full text |Cite
|
Sign up to set email alerts
|

Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations

Abstract: Liposome-based drug delivery systems composed of DOPE stabilized with cholesteryl hemisuccinate (CHMS) have been proposed as a drug delivery mechanism with pH-triggered release as the anionic form (CHSa) is protonated (CHS) at reduced pH; PEGylation is known to decrease this pH sensitivity. In this manuscript, we set out to use molecular dynamics (MD) simulations with a model with all-atom resolution to provide insight into why incorporation of poly(ethyleneglycol) (PEG) into DOPE–CHMS liposomes reduces their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 83 publications
0
5
0
Order By: Relevance
“…This finding indicates that the S CD of the phospholipids in the conjugate was lower than that of cholesterol. But S CD in cholesterol-undecanoate-glucose conjugate is higher than both arbutin and undecane-glucose conjugate, which means, compare with arbutin and undecane-glucose conjugate, the cholesterol-undecanoate-glucose conjugate can make phospholipid bilayers more order and compact [ 56 , 57 ]. It could conclude that PLPC/cholesterol-undecanoate-glucose conjugate liposomes could encapsulate more drugs and stably in vivo deliver drugs to target the brain.…”
Section: Resultsmentioning
confidence: 99%
“…This finding indicates that the S CD of the phospholipids in the conjugate was lower than that of cholesterol. But S CD in cholesterol-undecanoate-glucose conjugate is higher than both arbutin and undecane-glucose conjugate, which means, compare with arbutin and undecane-glucose conjugate, the cholesterol-undecanoate-glucose conjugate can make phospholipid bilayers more order and compact [ 56 , 57 ]. It could conclude that PLPC/cholesterol-undecanoate-glucose conjugate liposomes could encapsulate more drugs and stably in vivo deliver drugs to target the brain.…”
Section: Resultsmentioning
confidence: 99%
“…124 Mahmoudzadeh et al investigated how PEGylation reduces the sensitivity of pH-sensitive liposomes. 125 For this purpose, they modeled bilayered systems composed of dioleoylphosphatidylethanolamine (DOPE) with cholesterol, cholesteryl hemisuccinate in the neutral state (CHS) and in the anionic form (CHSa). The systems were modeled with and without PEGylated DOPE.…”
Section: ■ Lipid-based Drug Formulationsmentioning
confidence: 99%
“…pH-sensitive liposomes have been introduced to disrupt the enzymatic degradation of liposomes, which leads to the degradation of the encapsulated drug(s) after entering to the cell . Mahmoudzadeh et al investigated how PEGylation reduces the sensitivity of pH-sensitive liposomes . For this purpose, they modeled bilayered systems composed of dioleoylphosphatidylethanolamine (DOPE) with cholesterol, cholesteryl hemisuccinate in the neutral state (CHS) and in the anionic form (CHSa).…”
Section: Lipid-based Drug Formulationsmentioning
confidence: 99%
“…LIPOs were prepared via a thin-film hydration method with subsequent extrusion. A PEGylated lipid was incorporated into the formulation to provide additional stability [42,43]. The composition of prepared formulations and their physicochemical properties are displayed in Table 1.…”
Section: Physicochemical Characterizationsmentioning
confidence: 99%